Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.
about
The genome of Melanoplus sanguinipes entomopoxvirusThe scanning model for translation: an updateSalmon Gill Poxvirus, the Deepest Representative of the Chordopoxvirinae.A homolog of the vaccinia virus D13L rifampicin resistance gene is in the entomopoxvirus of the parasitic wasp, Diachasmimorpha longicaudataVaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis.Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.A cellular protein binds vaccinia virus late promoters and activates transcription in vitro.Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesisVaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivoProtective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tailThe vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.Fowlpox virus encodes a novel DNA repair enzyme, CPD-photolyase, that restores infectivity of UV light-damaged virusTransfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vectorAttenuation of vaccinia virus by the expression of human Flt3 ligandMessenger RNAs of a strongly-expressed late gene of cowpox virus contain 5'-terminal poly(A) sequencesPhase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals.Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factorSimultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencingVaccinia virus gene encoding a 30-kilodalton subunit of the viral DNA-dependent RNA polymeraseIntroduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genesVaccinia virus J1R protein: a viral membrane protein that is essential for virion morphogenesis.Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusionsIdentification of a vaccinia virus gene encoding a type I DNA topoisomerase.In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.Identification of the vaccinia virus gene encoding nucleoside triphosphate phosphohydrolase I, a DNA-dependent ATPaseA prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers.Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates.The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.Orthopoxvirus targets for the development of antiviral therapies.Conserved sequences near the early transcription start sites of vaccinia virus.Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs.Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein
P2860
Q24516950-A815FB5F-6757-434A-8581-CF501C7CB8F3Q24679648-2C7E906C-409F-4B84-AF9B-9476EAD64E36Q30978284-4D46ECB7-C678-4C6E-81B7-B0C285D0235FQ33546567-506A4BC2-A0D2-42CD-8541-4C5F95D75690Q33770781-0A70B9C1-F468-4CFA-9A5A-463DBF418E1DQ33780579-3AA897A2-639F-4DEA-A74F-E4E03DD38EB8Q33782698-F0EAF2AD-83C6-45F2-9078-8B4B7213AA6DQ33799135-6627C8E1-8530-4B62-AE1C-F28F00B35902Q33801656-570889FE-DC7F-4DE8-A810-C2C683930AD4Q33803714-038226EB-2192-4D87-922D-5510D7F341EDQ33809797-D8C1A589-09A5-4EDF-A676-D1E73E899256Q33811821-C54BAB5D-94F7-4A36-9427-8A73B3191BDAQ33826983-E7AA4BCC-EA0A-4C4E-94E3-B3D61FC44A9FQ33837349-3137257C-D907-4A36-A936-73E1B697982FQ33849466-E471BFEE-7154-4AE6-AE7B-79EA73B7BEC1Q33907236-E2BA40AB-9F73-4A71-8348-88913511715EQ33929995-31FBA092-F6A7-4D06-A290-957E434385D4Q33930815-4A879CE6-05BE-45B3-853D-FDC9D7232616Q33937787-9E2B6BF3-E390-4FC0-9F9A-71FB914746BAQ33953053-5E1D4454-C4AF-4412-8E98-862B574376CAQ34090814-27174FBE-B6DF-41A8-AC98-7EF9FDA0FA0BQ34120696-35C81BB3-07B4-4017-8E64-996D05C17589Q34345472-D542F7B2-74FB-41F9-B8CE-8B2CDE96C774Q34347131-FB07071A-1753-40D0-A0E3-C240CE67B528Q34355408-9B9CCADA-70CD-4F11-9E67-A3D14DA78BF0Q34357613-7C9C32F8-24CE-4FF3-B1F1-5A1D743FC0C5Q34376700-0EFA1EF3-4CDF-4E9B-93D3-87CD7DC93F5AQ35076857-04840B42-E83C-4200-A7D1-0228A4DD6C13Q35154570-644ACD1C-24A7-4542-8886-C7E95BC1653EQ35595612-3F0F8C69-2066-45FB-93E6-12BC3C8F05A9Q35611968-75F036B8-D2D2-4385-AD36-948D7A52832EQ35835061-DDAA4B38-339F-4A88-805C-668B4FF78D45Q35849628-40DFC587-43DD-4965-9772-F2ADC91411C5Q35870032-6032C017-7C84-4324-92A3-D519B59A36E3Q35946213-968703C4-3D9B-4FED-9B29-7900ADCC590EQ35990356-A9184F45-9311-444F-A311-EF11B89D9947Q36074391-C9589DC5-1624-4778-B0F1-5F6AE599F942Q36118625-C271BDDC-715F-432C-AD10-BEF404E8E9C9Q36225693-CA8DD351-C6EE-40ED-875A-9E43F969E6F5Q36288076-DAD126A0-D8DA-4773-AF22-B90B4B10B413
P2860
Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.
description
1986 nî lūn-bûn
@nan
1986 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Conserved TAAATG sequence at t ...... the HindIII H genome fragment.
@ast
Conserved TAAATG sequence at t ...... the HindIII H genome fragment.
@en
type
label
Conserved TAAATG sequence at t ...... the HindIII H genome fragment.
@ast
Conserved TAAATG sequence at t ...... the HindIII H genome fragment.
@en
prefLabel
Conserved TAAATG sequence at t ...... the HindIII H genome fragment.
@ast
Conserved TAAATG sequence at t ...... the HindIII H genome fragment.
@en
P2093
P2860
P1433
P1476
Conserved TAAATG sequence at t ...... the HindIII H genome fragment
@en
P2093
P2860
P304
P407
P577
1986-11-01T00:00:00Z